Mechanisms of action of atypical antipsychotic drugs: a critical analysis B. J. KinonJ. A. Lieberman Review Pages: 2 - 34
Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective “D1-like” dopamine receptor agonist A 68930 and selective “D2-like” agonist RU 24213 A. M. DeveneyJ. L. Waddington Original Investigation Pages: 40 - 49
Olanzapine, a novel atypical antipsychotic, reversesd-amphetamine-induced inhibition of midbrain dopamine cells M. E. StocktonK. Rasmussen Original Investigation Pages: 50 - 56
Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding A. SchotteP. F. M. JanssenJ. E. Leysen Original Investigation Pages: 57 - 73
Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain P. HertelG. G. NomikosT. H. Svensson Original Investigation Pages: 74 - 86
Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, α1-adrenergic and muscarinic receptors in vivo in rats F. P. BymasterS. K. Hemrick-LueckeR. W. Fuller Original Investigation Pages: 87 - 94
5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats J. H. KehneR. A. PadichC. J. Schmidt Original Investigation Pages: 95 - 106
5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats R. A. PadichT. C. McCloskeyJ. H. Kehne Original Investigation Pages: 107 - 116
Inhibitory effects on the discriminative stimulus properties ofd-amphetamine by classical and newer antipsychotics do not correlate with antipsychotic activity. Relation to effects on the reward system? J. Arnt Original Investigation Pages: 117 - 125
Differential effect of antipsychotics on place navigation of rats in the Morris water maze T. Skarsfeldt Original Investigation Pages: 126 - 133
Behavioral effects of sertindole, risperidone, clozapine and haloperidol inCebus monkeys D. E. Casey Original Investigation Pages: 134 - 140
The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomography C. J. BenchA. A. LammerstmaL. Y. Brannick Original Investigation Pages: 141 - 147
Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine — a123 IBZM single photon emission tomography (SPET) study L. S. PilowskyG. F. BusattoV. Nohria Original Investigation Pages: 148 - 153
In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia J. L. MartinotM. H. Dao-CastellanaM. L. Paillere-Martinot Original Investigation Pages: 154 - 158
Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial C. M. Beasley JrT. SangerS. Hamilton Original Investigation Pages: 159 - 167
A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia D. P. van KammenJ. P. McEvoyT. B. Sebree Original Investigation Pages: 168 - 175
Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine H. Y. MeltzerM. A. LeeP. A. Cola Original Investigation Pages: 176 - 187
Clozapine versus typical antipsychotics a retro- and prospective study of extrapyramidal side effects L. PeacockH. LublinT. Solgaard Original Investigation Pages: 188 - 196
Effect of treatment duration on plasma levels of clozapine andN-desmethylclozapine in men and women M. FabrazzoG. EspositoM. May Original Investigation Pages: 197 - 200
Does eosinophilia predict clozapine induced neutropenia? M. HummerB. Sperner-UnterwegerH. Oberbauer Original Investigation Pages: 201 - 204
